Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,555 | -58,197 | -45,312 | -31,433 | -15,758 |
| Depreciation Amortization | 284 | 1,251 | 944 | 634 | 317 |
| Other Working Capital | -3,568 | 3,462 | 2,631 | 784 | -927 |
| Other Operating Activity | 1,867 | 6,823 | 5,183 | 3,656 | 1,838 |
| Operating Cash Flow | $-14,972 | $-46,661 | $-36,554 | $-26,359 | $-14,530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -546 | -122 | -107 | -59 |
| Purchase Of Investment | -29,405 | -174,897 | -135,792 | -96,285 | -52,625 |
| Sale Of Investment | 44,000 | 213,244 | 160,744 | 110,744 | 55,744 |
| Investing Cash Flow | $14,587 | $37,801 | $24,830 | $14,352 | $3,060 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 141 | 117 | 117 | N/A |
| Financing Cash Flow | $N/A | $141 | $117 | $117 | $N/A |
| Beginning Cash Position | 18,428 | 27,147 | 27,147 | 27,147 | 27,147 |
| End Cash Position | 18,043 | 18,428 | 15,540 | 15,257 | 15,677 |
| Net Cash Flow | $-385 | $-8,719 | $-11,607 | $-11,890 | $-11,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,972 | -46,661 | -36,554 | -26,359 | -14,530 |
| Capital Expenditure | -8 | -546 | -122 | -107 | -59 |
| Free Cash Flow | -14,980 | -47,207 | -36,676 | -26,466 | -14,589 |